Burning Rock Biotech (BNR) Total Liabilities (2019 - 2026)

Burning Rock Biotech's Total Liabilities history runs 8 years deep, the most recent figure standing at $39.3 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 0.89% year-over-year to $39.3 million; the TTM figure through Mar 2026 stood at $39.3 million (up 0.89% YoY), while the FY2025 annual figure was $40.8 million, down 2.26% from the prior year.
• Total Liabilities for Q1 2026 stood at $39.3 million, down from $40.2 million in the prior quarter.
• The five-year high for Total Liabilities was $71.5 million in Q1 2022, with the low at $36.4 million in Q2 2025.
• The 5-year median for Total Liabilities is $42.4 million (2024), against an average of $47.5 million.
• The sharpest annual moves came in 2022 and 2023: Total Liabilities jumped 34.31% in 2022, then sank 37.48% in 2023.
• Burning Rock Biotech's Total Liabilities stood at $60.3 million in 2022, then tumbled by 37.48% to $37.7 million in 2023, then grew by 12.37% to $42.4 million in 2024, then retreated by 5.17% to $40.2 million in 2025, then slipped by 2.15% to $39.3 million in 2026.
• Business Quant data shows BNR's Total Liabilities at $39.3 million in Q1 2026, $40.2 million in Q4 2025, and $36.9 million in Q3 2025.